Share via Email


* Email To: (Separate multiple addresses with a semicolon)
* Your Name:
* Email From: (Your IP Address is 44.213.60.33)
* Email Subject: (personalize your message)


Email Content:

STOP PRESS

07/03/2024
Moderna Receives U.S. Grant for H5N1 Human Vaccine


The U.S. Biomedical Advanced Research and Development Authority (BARDA) has awarded Moderna $176 million to produce an avian influenza H5N1 vaccine for humans applying mRNA technology as used for COVID vaccines.  Moderna is currently testing their mRNA-1018 vaccine in volunteers with results available by December.